Mycrodose Overview

  • Year Founded
  • 2020

Year Founded

  • Status
  • Private

  • Employees
  • 12

Employees

  • Latest Deal Type
  • Early Stage VC
  • (Cancelled)

  • Investors
  • 9

Mycrodose General Information

Description

Developer of advanced drug delivery systems designed to treat cancer-related conditions, mental health disorders, and cognitive degenerative diseases. The company specializes in the development of advanced drug delivery (ADD) systems utilizing psychedelic compounds to treat mental health and cognitive degenerative diseases, enabling patients to get advanced drugs to treat them fast through a safe and scalable approach.

Contact Information

Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Corporate Office
  • 5940 Pacific Mesa Court
  • Suite 209
  • San Diego, CA 92121
  • United States
+1 (619)
Primary Industry
Drug Discovery
Other Industries
Pharmaceuticals
Vertical(s)
Corporate Office
  • 5940 Pacific Mesa Court
  • Suite 209
  • San Diego, CA 92121
  • United States
+1 (619)

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Mycrodose Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
2. Early Stage VC 21-Oct-2021 Cancelled Startup
1. Seed Round 07-Sep-2021 Completed Startup
To view Mycrodose’s complete valuation and funding history, request access »

Mycrodose Patents

Mycrodose Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
US-20230026731-A1 Transdermal system, formulation, and method for the therapeutic administration of a psychedelic agent Inactive 31-Mar-2021
WO-2022212789-A1 Transdermal system, formulation, and method for the therapeutic administration of a psychedelic agent Inactive 31-Mar-2021
WO-2022221072-A1 Transdermal system, formulation, and method for the therapeutic administration of a psychedelic agent Inactive 31-Mar-2021 A61K31/4045

Mycrodose Signals

Growth Rate

Weekly
Growth
Weekly Growth

Size Multiple

Median
Size Multiple

Key Data Points

Similarweb Unique Visitors

Majestic Referring Domains

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Mycrodose Investors (9)

Investor Name Investor Type Holding Investor Since Participating Rounds
Ambria Capital Venture Capital Minority
Four Acres Capital Venture Capital Minority
H.E.N.R.Y Collective Venture Capital Minority
K2 & Associates Investment Management Hedge Fund
Negev Capital Venture Capital Minority
You’re viewing 5 of 9 investors. Get the full list »

Mycrodose Investments (1)

Mycrodose’s most recent deal was a Joint Venture with Kelai Pharmaceutical. The deal was made on 01-Jan-2021.

Company Name Deal Date Deal Type Deal Size Industry Lead Partner
Kelai Pharmaceutical 01-Jan-2021 Joint Venture Drug Discovery
To view Mycrodose’s complete investments history, request access »

Mycrodose FAQs

  • When was Mycrodose founded?

    Mycrodose was founded in 2020.

  • Where is Mycrodose headquartered?

    Mycrodose is headquartered in San Diego, CA.

  • What is the size of Mycrodose?

    Mycrodose has 12 total employees.

  • What industry is Mycrodose in?

    Mycrodose’s primary industry is Drug Discovery.

  • Is Mycrodose a private or public company?

    Mycrodose is a Private company.

  • What is Mycrodose’s current revenue?

    The current revenue for Mycrodose is .

  • How much funding has Mycrodose raised over time?

    Mycrodose has raised $1.5M.

  • Who are Mycrodose’s investors?

    Ambria Capital, Four Acres Capital, H.E.N.R.Y Collective, K2 & Associates Investment Management, and Negev Capital are 5 of 9 investors who have invested in Mycrodose.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more
  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process